Case Studies

Discovery of a Novel Metabolic Signature Correlated with Resistance to anti-PD-1 Therapy in NSCLC

First AI Digital Pathology Solution Deployed for Prospective Enrollment in a Multispecific Trial

Virtual Multiplexing of Sequential IHCs & H&E for Co-Expression Analysis of Tumor and Immune Biomarkers

AI-augmented Scoring of the Bystander Effect for Effective ADC Patient Selection

AI-aided HER2 Ultralow Scoring to Enable Accurate Patient Stratification for ADCs

AI-aided Scoring of PD-L1 Expression Could Accelerate Trial Enrollment for NSCLC